Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status: Archived
mi
from
Stanford, CA
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status: Archived
Updated: 1/1/1970
Stanford university Hospital and Clinics
mi
from
Stanford, CA
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status: Archived
mi
from
Chicago, IL
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status: Archived
Updated: 1/1/1970
Northwestern University
mi
from
Chicago, IL
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status: Archived
mi
from
Rochester, MN
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
mi
from
Rochester, MN
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status: Archived
mi
from
Cincinnati, OH
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status: Archived
Updated: 1/1/1970
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status: Archived
mi
from
Springfield, VA
Efficacy and Safety of QAX576 in Patients With Eosinophilic Esophagitis
A Double Blinded Randomized Placebo-controlled Trial of Intravenous QAX576 in the Treatment of Eosinophilic Esophagitis (EoE)
Status: Archived
Updated: 1/1/1970
O & O Alpan
mi
from
Springfield, VA
Prevalence of Vitamin D Deficiency in Type 1 Diabetes Mellitus and Effect on Insulin Requirements After Supplementation With Vitamin D
Prevalence of Vitamin D Deficiency in Type 1 Diabetes Mellitus and Effect on Insulin Requirements After Supplementation With Vitamin D-A Pilot Study
Status: Archived
mi
from
Royal oak, MI
Prevalence of Vitamin D Deficiency in Type 1 Diabetes Mellitus and Effect on Insulin Requirements After Supplementation With Vitamin D
Prevalence of Vitamin D Deficiency in Type 1 Diabetes Mellitus and Effect on Insulin Requirements After Supplementation With Vitamin D-A Pilot Study
Status: Archived
Updated: 1/1/1970
Wiiliam Beaumont Hospital
mi
from
Royal oak, MI
Isoflurane Preconditioning for Liver Resections
Isoflurane Induced Anesthetic Preconditioning in Elective Liver Resection
Status: Archived
mi
from
Newark, NJ
Isoflurane Preconditioning for Liver Resections
Isoflurane Induced Anesthetic Preconditioning in Elective Liver Resection
Status: Archived
Updated: 1/1/1970
UMDNJ-University Hospital
mi
from
Newark, NJ
Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease
Comparison of Immune Response to the Human Papillomavirus Vaccine in Young Women With and Without Inflammatory Bowel Disease
Status: Archived
mi
from
Rochester, MN
Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease
Comparison of Immune Response to the Human Papillomavirus Vaccine in Young Women With and Without Inflammatory Bowel Disease
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
mi
from
Rochester, MN
Electrohydraulic Versus Laser Lithotripsy
Electrohydraulic Versus Laser Lithotripsy for Difficult to Remove Biliary Stones: A Randomized Study
Status: Archived
mi
from
Weston, FL
Electrohydraulic Versus Laser Lithotripsy
Electrohydraulic Versus Laser Lithotripsy for Difficult to Remove Biliary Stones: A Randomized Study
Status: Archived
Updated: 1/1/1970
Cleveland Clinic Florida
mi
from
Weston, FL
Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model
Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model
Status: Archived
mi
from
Springfield, VA
Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model
Identifying Responders to Xolair (Omalizumab) Using Eosinophilic Esophagitis as a Disease Model
Status: Archived
Updated: 1/1/1970
O & O Alpan
mi
from
Springfield, VA
Same-day, Reduced Volume Bowel Preparation
Evaluating the Effectiveness of a Same-day, Reduced Volume Polyethylene Glycol + Electrolyte Solution (PEG-ELS) Bowel Preparation for Afternoon Colonoscopies
Status: Archived
mi
from
Boston, MA
Same-day, Reduced Volume Bowel Preparation
Evaluating the Effectiveness of a Same-day, Reduced Volume Polyethylene Glycol + Electrolyte Solution (PEG-ELS) Bowel Preparation for Afternoon Colonoscopies
Status: Archived
Updated: 1/1/1970
Boston Med Center
mi
from
Boston, MA
Provant Therapy of Venous Stasis Ulcer Trial
Provant Therapy of Venous Stasis Ulcer Trial
Status: Archived
mi
from
Chicago, IL
Provant Therapy of Venous Stasis Ulcer Trial
Provant Therapy of Venous Stasis Ulcer Trial
Status: Archived
Updated: 1/1/1970
Veterans Affairs Medical Center - Lakeside Chicago
mi
from
Chicago, IL
Provant Therapy of Venous Stasis Ulcer Trial
Provant Therapy of Venous Stasis Ulcer Trial
Status: Archived
mi
from
Los Angeles, CA
Provant Therapy of Venous Stasis Ulcer Trial
Provant Therapy of Venous Stasis Ulcer Trial
Status: Archived
Updated: 1/1/1970
West Los Angeles VA Medical Center
mi
from
Los Angeles, CA
Vitamin D Supplementation Reduces Renin-Angiotensin System Activity in Obesity
Vitamin D Deficiency Augments Renin-Angiotensin System Activity in Obesity
Status: Archived
mi
from
Boston, MA
Vitamin D Supplementation Reduces Renin-Angiotensin System Activity in Obesity
Vitamin D Deficiency Augments Renin-Angiotensin System Activity in Obesity
Status: Archived
Updated: 1/1/1970
Brigham and Women's Hosp
mi
from
Boston, MA
The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS)
The Role of Intestinal Inflammation in the Pathophysiology of IBS
Status: Archived
mi
from
Chapel Hill, NC
The Role of Intestinal Inflammation in Irritable Bowel Syndrome (IBS)
The Role of Intestinal Inflammation in the Pathophysiology of IBS
Status: Archived
Updated: 1/1/1970
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Effect of Intermittent Pneumatic Compression on Ulcer Healing in Subjects With Secondary Lymphedema
Intermittent, Gradient, Pneumatic Compression Plus Standard Compression for Hard-To-Heal Venous Ulcers in Subjects With Secondary Lymphedema and Chronic Venous Insufficiency
Status: Archived
mi
from
New York, NY
Effect of Intermittent Pneumatic Compression on Ulcer Healing in Subjects With Secondary Lymphedema
Intermittent, Gradient, Pneumatic Compression Plus Standard Compression for Hard-To-Heal Venous Ulcers in Subjects With Secondary Lymphedema and Chronic Venous Insufficiency
Status: Archived
Updated: 1/1/1970
Center for Curative & Palliative Wound Care Calvary Hospital
mi
from
New York, NY
Feasibility of Translumenal Endoscopic Omental Patch Closure of Perforated Viscus
Feasibility of Translumenal Endoscopic Omental Patch Closure of Perforated Viscus
Status: Archived
mi
from
Rochester, MN
Feasibility of Translumenal Endoscopic Omental Patch Closure of Perforated Viscus
Feasibility of Translumenal Endoscopic Omental Patch Closure of Perforated Viscus
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
mi
from
Rochester, MN
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
mi
from
Tucson, AZ
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Southern Arizona VA Health Care System
mi
from
Tucson, AZ
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
mi
from
Los Angeles, CA
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
mi
from
Los Angeles, CA
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
mi
from
Lafayette, IN
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Horizon Oncology Center
mi
from
Lafayette, IN
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
mi
from
Baltimore, MD
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
mi
from
Detroit, MI
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Wayne State University/Detroit Medical Center
mi
from
Detroit, MI
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
mi
from
New Hyde Park, NY
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Arena Oncology Associates
mi
from
New Hyde Park, NY
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
mi
from
Rochester, NY
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
University of Rochester, James P. Wilmot Cancer Center
mi
from
Rochester, NY
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
mi
from
Rochester, NY
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
James P. Wilmot Cancer Center, University of Rochester
mi
from
Rochester, NY
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
mi
from
Philadelphia, PA
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Thomas Jefferson Hospital
mi
from
Philadelphia, PA
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
mi
from
Dallas, TX
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Texas Oncology - Baylor Charles A. Simmons Cancer Center
mi
from
Dallas, TX
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
mi
from
Houston, TX
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
mi
from
Tyler, TX
Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer
A Randomized, Open-label, Multi-center Phase II Study to Compare AUY922 With Docetaxel or Irinotecan in Adult Patients With Advanced Gastric Cancer, Who Have Progressed After One Line of Chemotherapy
Status: Archived
Updated: 1/1/1970
Texas Oncology-Tyler
mi
from
Tyler, TX
Mastery Learning Inguinal Hernia Repair
Mastery Learning Totally Extraperitoneal Inguinal Hernia Repair: Linking Surgical Simulation to Patient Level Outcomes
Status: Archived
mi
from
Rochester, MN
Mastery Learning Inguinal Hernia Repair
Mastery Learning Totally Extraperitoneal Inguinal Hernia Repair: Linking Surgical Simulation to Patient Level Outcomes
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
mi
from
Rochester, MN
A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis
A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis
Status: Archived
mi
from
Rochester, MN
A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis
A Pilot Study of Vancomycin or Metronidazole in Patients With Primary Sclerosing Cholangitis
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
mi
from
Rochester, MN
Gluten Intolerance in Patients With Diarrhea Predominant Irritable Bowel Syndrome
Gluten Intolerance in Irritable Bowel Syndrome With Diarrhea: The Role of HLA-DQ2
Status: Archived
mi
from
Rochester, MN
Gluten Intolerance in Patients With Diarrhea Predominant Irritable Bowel Syndrome
Gluten Intolerance in Irritable Bowel Syndrome With Diarrhea: The Role of HLA-DQ2
Status: Archived
Updated: 1/1/1970
Mayo Clinic Rochester
mi
from
Rochester, MN
Improving Bowel Preparation With an Educational Video
Improving Bowel Preparation With an Education Video
Status: Archived
mi
from
Boston, MA
Improving Bowel Preparation With an Educational Video
Improving Bowel Preparation With an Education Video
Status: Archived
Updated: 1/1/1970
Boston Med Center
mi
from
Boston, MA
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status: Archived
mi
from
San Diego, CA
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
San Diego, CA
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status: Archived
mi
from
Fort Lauderdale, FL
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Fort Lauderdale, FL
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status: Archived
mi
from
Honolulu, HI
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Honolulu, HI
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status: Archived
mi
from
Allentown, PA
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Allentown, PA
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status: Archived
mi
from
Houston, TX
An Ascending Multiple Dose Study Evaluating AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
A Randomized, Double-blind, Placebo-controlled, Ascending Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 167 in Healthy Men and Postmenopausal Women With Low Bone Mineral Density
Status: Archived
Updated: 1/1/1970
Clinical Research Facility
mi
from
Houston, TX
Utility of a Urine Screening Tool for Vitamin D Deficiency in Infants and Toddlers
Utility of the Urine Calcium Creatinine Ratio as a Screening Tool for Vitamin D Deficiency in Infants and Toddlers
Status: Archived
mi
from
Jacksonville, FL
Utility of a Urine Screening Tool for Vitamin D Deficiency in Infants and Toddlers
Utility of the Urine Calcium Creatinine Ratio as a Screening Tool for Vitamin D Deficiency in Infants and Toddlers
Status: Archived
Updated: 1/1/1970
Nemours Children's Clinic
mi
from
Jacksonville, FL
Use of INTEGRAâ„¢ Flowable Wound Matrix to Manage Diabetic Foot Ulcers
The Use of INTEGRAâ„¢ Flowable Wound Matrix to Manage Diabetic Foot Ulcers in High Risk Populations: A Prospective, Randomized, Controlled Trial
Status: Archived
mi
from
Washington,
Use of INTEGRAâ„¢ Flowable Wound Matrix to Manage Diabetic Foot Ulcers
The Use of INTEGRAâ„¢ Flowable Wound Matrix to Manage Diabetic Foot Ulcers in High Risk Populations: A Prospective, Randomized, Controlled Trial
Status: Archived
Updated: 1/1/1970
Georgetown Univ Med Ctr
mi
from
Washington,
Assessment of Gastric Emptying Speed in Patients Who Experience Diarrhea Following a Trigger Meal
Pilot Study: Assessment of Gastric and Intestinal Motility Following a Trigger Meal in Patients With Post Prandial Diarrhea
Status: Archived
mi
from
Hagerstown, MD
Assessment of Gastric Emptying Speed in Patients Who Experience Diarrhea Following a Trigger Meal
Pilot Study: Assessment of Gastric and Intestinal Motility Following a Trigger Meal in Patients With Post Prandial Diarrhea
Status: Archived
Updated: 1/1/1970
Dr. Mary E. Money
mi
from
Hagerstown, MD
Vagal Nerve Stimulation and Glucose Metabolism
The Effect of Vagal Nerve Stimulation on Enteroendocrine Secretion and Glucose Metabolism
Status: Archived
mi
from
Rochester, MN
Vagal Nerve Stimulation and Glucose Metabolism
The Effect of Vagal Nerve Stimulation on Enteroendocrine Secretion and Glucose Metabolism
Status: Archived
Updated: 1/1/1970
Mayo Clinic College of Medicine
mi
from
Rochester, MN
Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis
A Phase 4, Open-label, Multicenter, Prospective Study to Evaluate the Effect of Remission Status on the Ability to Maintain or Achieve Clinical and Endoscopic Remission During a 12-Month, Long-term Maintenance Phase With 2.4g/Day MMX Mesalamine/Mesalazine Once Daily in Adult Subjects With Ulcerative Colitis
Status: Archived
mi
from
Birmingham, AL
Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis
A Phase 4, Open-label, Multicenter, Prospective Study to Evaluate the Effect of Remission Status on the Ability to Maintain or Achieve Clinical and Endoscopic Remission During a 12-Month, Long-term Maintenance Phase With 2.4g/Day MMX Mesalamine/Mesalazine Once Daily in Adult Subjects With Ulcerative Colitis
Status: Archived
Updated: 1/1/1970
Birmingham Gastroenterology Associates P.C.
mi
from
Birmingham, AL
Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis
A Phase 4, Open-label, Multicenter, Prospective Study to Evaluate the Effect of Remission Status on the Ability to Maintain or Achieve Clinical and Endoscopic Remission During a 12-Month, Long-term Maintenance Phase With 2.4g/Day MMX Mesalamine/Mesalazine Once Daily in Adult Subjects With Ulcerative Colitis
Status: Archived
mi
from
Anaheim, CA
Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis
A Phase 4, Open-label, Multicenter, Prospective Study to Evaluate the Effect of Remission Status on the Ability to Maintain or Achieve Clinical and Endoscopic Remission During a 12-Month, Long-term Maintenance Phase With 2.4g/Day MMX Mesalamine/Mesalazine Once Daily in Adult Subjects With Ulcerative Colitis
Status: Archived
Updated: 1/1/1970
Advanced Clinical Research Institute
mi
from
Anaheim, CA
Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis
A Phase 4, Open-label, Multicenter, Prospective Study to Evaluate the Effect of Remission Status on the Ability to Maintain or Achieve Clinical and Endoscopic Remission During a 12-Month, Long-term Maintenance Phase With 2.4g/Day MMX Mesalamine/Mesalazine Once Daily in Adult Subjects With Ulcerative Colitis
Status: Archived
mi
from
Garden Grove, CA
Ability to Maintain or Achieve Clinical and Endoscopic Remission With MMX Mesalamine Once Daily in Adults With Ulcerative Colitis
A Phase 4, Open-label, Multicenter, Prospective Study to Evaluate the Effect of Remission Status on the Ability to Maintain or Achieve Clinical and Endoscopic Remission During a 12-Month, Long-term Maintenance Phase With 2.4g/Day MMX Mesalamine/Mesalazine Once Daily in Adult Subjects With Ulcerative Colitis
Status: Archived
Updated: 1/1/1970
Digestive & Liver Disease Specialists
mi
from
Garden Grove, CA